Who
Kathryn E. Falberg
Director
Company insider
Files Form 4 as: Director, Arcus Biosciences; Director, Nuvation Bio; Director, The Trade Desk; Director, Tricida; Director, UroGen Pharma; Director, Aimmune Therapeutics; Director, Axovant Sciences; Director, Medivation.
In numbers
- Trades disclosed
- 270
- Buys
- 26
- Sells
- 18
- Bought
- $13.3M
- Sold
- $87.3M
- Companies
- 14
- Companies where not an officer
- 12
- First trade
- 15 May 2007
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —5,700 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,900 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,900 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —5,700 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —123,397 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —123,397 at $0.00 | filing |
| 23 Mar 2026filed 25 Mar 2026 | TTD The Trade DeskAdvertising & Marketing | SEC FORM 4 Code D | —1,226 at $0.00 | filing |
| 23 Mar 2026filed 25 Mar 2026 | TTD The Trade DeskAdvertising & Marketing | SEC FORM 4 Code D | $13K212 at $59.17 | filing |
| 23 Mar 2026filed 25 Mar 2026 | TTD The Trade DeskAdvertising & Marketing | SEC FORM 4 Code D | $18K296 at $59.17 | filing |
| 23 Mar 2026filed 25 Mar 2026 | TTD The Trade DeskAdvertising & Marketing | SEC FORM 4 Code D | $13K212 at $59.17 | filing |
| 23 Mar 2026filed 25 Mar 2026 | TTD The Trade DeskAdvertising & Marketing | SEC FORM 4 Code D | —1,226 at $0.00 | filing |
| 23 Mar 2026filed 25 Mar 2026 | TTD The Trade DeskAdvertising & Marketing | SEC FORM 4 Code D | $13K212 at $59.17 | filing |
| 23 Mar 2026filed 25 Mar 2026 | TTD The Trade DeskAdvertising & Marketing | SEC FORM 4 Code D | $18K296 at $59.17 | filing |
| 23 Mar 2026filed 25 Mar 2026 | TTD The Trade DeskAdvertising & Marketing | SEC FORM 4 Code D | $13K212 at $59.17 | filing |
| 5 Mar 2026filed 9 Mar 2026 | TTD The Trade DeskAdvertising & Marketing | SEC FORM 4 Sold | $3.1M102,828 at $30.45 | filing |
| 5 Mar 2026filed 9 Mar 2026 | TTD The Trade DeskAdvertising & Marketing | SEC FORM 4 Sold | $1.5M50,000 at $30.48 | filing |
| 5 Mar 2026filed 9 Mar 2026 | TTD The Trade DeskAdvertising & Marketing | SEC FORM 4 Sold | $3.1M102,828 at $30.45 | filing |
| 5 Mar 2026filed 9 Mar 2026 | TTD The Trade DeskAdvertising & Marketing | SEC FORM 4 Sold | $1.5M50,000 at $30.48 | filing |
| 10 Jun 2025filed 12 Jun 2025 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,300 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —13,300 at $0.00 | filing |
News
Contrasting TEN (NASDAQ:XHLD) and Trade Desk (NASDAQ:TTD)TTD · dailypolitical.com · 20 Oct 2026Financial Review: Echostar (NASDAQ:ECHO) vs. Trade Desk (NASDAQ:TTD)TTD · tickerreport.com · 18 Oct 2026Trade Desk (NASDAQ:TTD) & Beasley Broadcast Group (NASDAQ:BBGI) Head-To-Head AnalysisTTD · dailypolitical.com · 12 Oct 2026
0 headlines in the last 90 days name Kathryn E. Falberg; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.